Sign In
Buy EVGN
$0.471
-0.0184 (-3.76%)
At Close: Jul 31, 2026
LAV321demonstrated strong results in its third consecutive year of field trials in Europe REHOVOT, Israel , Nov. 19, 2024 /PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company and subsidiar
EverGen Infrastructure Announces Dates for 2024 Third Quarter Financial Results and Conference Call
04:00pm, Wednesday, 13'th Nov 2024
VANCOUVER, British Columbia--(BUSINESS WIRE)--EverGen Infrastructure Corp. (“EverGen” or the “Company”) (TSXV: EVGN) (OTCQX: EVGIF), today announced plans to release its 2024 third quarter fin
Lavie Bio Announces Commercial Expansion of Yalos® as Seed-Treatment for Soybean, Following Successful Field Trials
07:00am, Tuesday, 12'th Nov 2024
Lavie Bio intends to commence Yalos® sales for soybean in 2025 US spring season REHOVOT, Israel , Nov. 12, 2024 /PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company and a subsidiary o
Evogene Schedules Third Quarter 2024 Financial Results Release
07:00am, Thursday, 07'th Nov 2024
Zoom conference call scheduled for November 21, 2024, 9:00 AM ET REHOVOT, Israel , Nov. 7, 2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targe
Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design
08:00am, Thursday, 31'st Oct 2024
The collaboration has the power to foster breakthroughs in small molecule innovation for life science-based products REHOVOT, Israel , Oct. 31, 2024 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE:
The shipment, comprising over 100 tons, was delivered to company's customer in Africa REHOVOT, Israel , Oct. 29, 2024 /PRNewswire/ -- Casterra Ag Ltd. ("Casterra"), an integrated castor cultivation so
Following a successful first year, Israel Innovation Authority (IIA) approved financing second year of collaboration HAZEVA and REHOVOT, Israel , Oct. 8, 2024 /PRNewswire/ -- Watershed AC ("Watershed"
EverGen Infrastructure Corp. Announces Change of Auditors
04:22pm, Monday, 07'th Oct 2024
VANCOUVER, British Columbia--(BUSINESS WIRE)--EverGen Infrastructure Corp. (“EverGen” or the “Company”) (TSXV: EVGN) (OTCQX: EVGIF), announces that it has changed auditors from Pricewaterhouse
The technology aims to reduce application costs, extend shelf life, and prolong bacterial viability after field application REHOVOT, Israel , Sept. 30, 2024 /PRNewswire/ -- Lavie Bio Ltd.
Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private Placement
08:55am, Friday, 23'rd Aug 2024
REHOVOT, Israel , Aug. 23, 2024 /PRNewswire/ -- Evogene Ltd. ("Evogene" or the "Company") (Nasdaq: EVGN, TASE: EVGN), a leading computational biology company aiming to revolutionize life-science-based
Evogene Ltd. (EVGN) Q2 2024 Earnings Call Transcript
05:42pm, Thursday, 22'nd Aug 2024
Evogene Ltd. (NASDAQ:EVGN ) Q2 2024 Earnings Conference Call August 22, 2024 9:00 AM ET Company Participants Ofer Haviv - President and CEO Yaron Eldad - CFO Yoash Zohar - CEO, Casterra Dan Jacob Gelv
EVGN Stock Earnings: Evogene Misses EPS, Beats Revenue for Q2 2024
11:53am, Thursday, 22'nd Aug 2024
Evogene (NASDAQ: EVGN ) just reported results for the second quarter of 2024. Evogene reported earnings per share of -$1.06.
Evogene Reports Second Quarter 2024 Financial Results
07:00am, Thursday, 22'nd Aug 2024
Conference call and webcast: today, August 22 , 2024, 9:00 am ET Financial and Business Highlights: H1 2024 revenues $5.1M, up from $1.3M in H1 2023; Q2 2024 revenues $914K, up from $654K in Q2 2023.
Evogene Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
07:11am, Monday, 12'th Aug 2024
REHOVOT, Israel , Aug. 12, 2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) (the "Company", "Evogene"), a leading computational biology company targeting to revolutionize life-science pr
Evogene Schedules Second Quarter 2024 Financial Results Release
07:00am, Monday, 12'th Aug 2024
Zoom conference call scheduled for 9:00 AM ET REHOVOT, Israel , Aug. 12, 2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutioni
